Projects per year
Organization profile
Organization profile
The Masonic Cancer Center enriches and supports the work of its members by providing an opportunity for professionals from a variety of academic backgrounds to interact and collaborate in multidisciplinary research programs, including: prevention and etiology, survivorship, carcinogenesis and chemoprevention, genetic mechanisms of cancer, tumor microenvironment, immunology, cell signaling, translational research, and transplant biology and therapy.
Fingerprint Dive into the research topics where Masonic Cancer Center is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Madjda Bellamri
- Carcinogenesis and Chemoprevention - Researcher
- Masonic Cancer Center - Post-Doctoral Associate
Person: Researcher, Professional-in-Training
Projects
Development of a DNA Adductome Database
Guo, J., Villalta, P. W. & Walmsley, S. J.
NIH NATL INST OF ENVIRON HEALTH SCIENCES
9/24/19 → 7/31/21
Project: Research project
Minnesota HHEAR Targeted Analysis Laboratory
Peterson, L. A., Balbo, S., Gross, M. D., Hecht, S. S., Murphy, S. E., Stepanov, I., Turesky, R. & Villalta, P. W.
NIH NATL INST OF ENVIRON HEALTH SCIENCES
9/5/19 → 5/31/24
Project: Research project
Profiling DNA adducts in formalin fixed paraffin embedded human colorectal tissue
NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/19 → 8/31/21
Project: Research project
Research Output
A novel gene editing system to treat both Tay–Sachs and Sandhoff diseases
Ou, L., Przybilla, M. J., Tăbăran, A. F., Overn, P., O’Sullivan, M. G., Jiang, X., Sidhu, R., Kell, P. J., Ory, D. S. & Whitley, C. B., Jan 1 2020, (Accepted/In press) In : Gene therapy.Research output: Contribution to journal › Article
A perspective and framework for developing sample type specific databases for LC/MS-based clinical metabolomics
Reisdorph, N. A., Walmsley, S. & Reisdorph, R., Jan 2020, In : Metabolites. 10, 1, 8.Research output: Contribution to journal › Article
Open Access
CD200 checkpoint reversal: A novel approach to immunotherapy a C
Xiong, Z., Mesias, E. A., Elizabeth Pluhar, G., Rathe, S. K., Largaespada, D. A., Sham, Y. Y., Moertel, C. L. & Olin, M. R., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 232-241 10 p.Research output: Contribution to journal › Article
Open Access